GSK plc announced with effect from 11 March 2024, Dr. Hal Dietz has been appointed a member of the Nominations & Corporate Governance Committee. This appointment is in addition to his role as Chair of the Science Committee and membership of the Chairs' Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,786 GBX | +0.44% | +0.66% | +23.21% |
10:53am | Rate outlook weighs on equities | |
10:37am | GSK: successful verdict in Zantac case | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.21% | 92.17B | |
+38.69% | 728B | |
+33.71% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+16.03% | 244B | |
+7.66% | 207B | |
-5.52% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK plc Appoints Hal Dietz as Member of Nominations & Corporate Governance Committee, Effective 11 March 2024